Ginkgo Bioworks Holdings, Inc. (DNA) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 460.85M |
| Enterprise Value | 733.54M |
| P/E Ratio | -2.52 |
| PEG Ratio | -0.16 |
| Price/Sales Ratio | 7.39 |
| Price/Book Ratio | 1.87 |
| Enterprise/Revenue | 10.32 |
| Enterprise/EBITDA | -5.52 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -2.6 |
| Operating Margin | -2.6 |
AD
Management Effectiveness
| Return On Assets | -0.29 |
| Return On Equity | -0.6 |
Income Statement
| Revenue | 170.16M |
| Revenue/Share | 1.8 |
| Gross Profit | 138.63M |
| EBITDA | -254.61M |
| Net Income | -312.76M |
| Diluted EPS | -5.64 |
Balance Sheet
| Total Cash | 302.16M |
| Total Cash/Share | 4.87 |
| Total Debt | 404.11M |
| Total Debt/Equity | 0.96 |
| Current Ratio | 4.57 |
| Book Value Per Share | 6.77 |
Price History
| 52-Week Change | -13.7 |
| 52-Week High | 17.58 |
| 52-Week Low | 5.37 |
| Moving Average 50 Days | 7.89 |
| Moving Average 200 Days | 8.29 |
Statistics
| Average Volume | 1.35M |
| Shares Outstanding | 65.32M |
| % Held by Institutions | 61.42 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
| Last Split Date | August 20, 2024 |
AD
